Valenti, Luca V. C. http://orcid.org/0000-0001-8909-0345
Moretti, Vittoria http://orcid.org/0000-0003-1150-5568
Article History
First Online: 3 November 2023
Competing interests
: L.V.C.V. has received speaking fees from Viatris and Novo Nordisk, consulted for Novo Nordisk, Pfizer, Boehringer Ingelheim, and Resalis, and received unrestricted grant support from Gilead. V.M. declares no competing interests.